From "Pharmaceutical Care and Health Care Utilization in an HMO" Effective Clinical Practice, March/April 2002. 49-57.
Figure 3. Adjusted change in utilization for the pharmaceutical care and usual care groups: intention-to-treat analysis. Data adjusted for gender, age, chronic condition group (heart vs. lung), comorbid conditions, and the outcome variable at baseline.>